Sebia – Capillary Electrophoresis for Hemoglobinopathy and Thalassemia Evaluation – On-demand Webinar
Revisit Sebia’s Educational Webinar on HbA1c Utilisation: Key Insights from Updated Lab Guidelines
We are excited to invite you to revisit Sebia’s educational webinar, “Capillary Electrophoresis for Hemoglobinopathy and Thalassemia Evaluation: A Case-Based Approach”, presented by Mark R. Girton, Clinical Assistant Professor at University of Michigan and Dr. Matthew C. Wagner, Scientific Affairs Specialist at Sebia. This webinar is a must-watch for laboratory professionals and clinicians involved in Haemoglobinopathies.
Why This Webinar Matters
Capillary Electrophoresis is one of the newer methods for the detection and evaluation of haemoglobinopathies. It improves upon the alkaline gel electrophoresis platform with a similar migration order, but sharper resolution, better quantitation, and tightly controlled migration such that individual variants can be distinguished from one another by small differences in presentation or migration position. However, it is one of several components of a standard haemoglobinopathy workup. Evaluation of the electrophoretic pattern in the context of confirmatory testing, CBC values, iron studies, peripheral blood smears, and patient history can provide surprising detail and insight into a patient’s diagnosis and clinical condition. The following presentation will demonstrate this through carefully selected clinical cases wherein slight (and in some cases large) deviations from a normal electrophoretic profile are given greater meaning through consideration of the whole patient chart.
Key Takeaways from the Webinar
- Evaluate a typical electrophoretic profile and distinguish whether it is “normal” or “abnormal” based on number of peaks, peak position, and presentation within or outside of normal % ranges.
- Distinguish between several normally encountered clinical conditions or haemoglobinopathies which may drive subtle changes in the electrophoretic pattern outside of “normal” ranges.
- Conclude that an electrophoretic pattern must be assessed in light of all available clinical testing
Abacus dx is the exclusive distributor of Sebia in Australia only.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
